JPWO2023114971A5 - - Google Patents

Info

Publication number
JPWO2023114971A5
JPWO2023114971A5 JP2024536373A JP2024536373A JPWO2023114971A5 JP WO2023114971 A5 JPWO2023114971 A5 JP WO2023114971A5 JP 2024536373 A JP2024536373 A JP 2024536373A JP 2024536373 A JP2024536373 A JP 2024536373A JP WO2023114971 A5 JPWO2023114971 A5 JP WO2023114971A5
Authority
JP
Japan
Prior art keywords
composition
kit
nitric oxide
citric acid
active pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547022A5 (https=
JP2024547022A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081754 external-priority patent/WO2023114971A1/en
Publication of JP2024547022A publication Critical patent/JP2024547022A/ja
Publication of JPWO2023114971A5 publication Critical patent/JPWO2023114971A5/ja
Publication of JP2024547022A5 publication Critical patent/JP2024547022A5/ja
Pending legal-status Critical Current

Links

JP2024536373A 2021-12-17 2022-12-16 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 Pending JP2024547022A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290928P 2021-12-17 2021-12-17
US63/290,928 2021-12-17
PCT/US2022/081754 WO2023114971A1 (en) 2021-12-17 2022-12-16 Nitric oxide-releasing nasal compositions and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024547022A JP2024547022A (ja) 2024-12-26
JPWO2023114971A5 true JPWO2023114971A5 (https=) 2025-12-09
JP2024547022A5 JP2024547022A5 (https=) 2025-12-09

Family

ID=86773604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536373A Pending JP2024547022A (ja) 2021-12-17 2022-12-16 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法

Country Status (9)

Country Link
US (1) US20250049841A1 (https=)
EP (1) EP4447946A4 (https=)
JP (1) JP2024547022A (https=)
KR (1) KR20240125633A (https=)
CN (1) CN118742298A (https=)
AU (1) AU2022409833A1 (https=)
CA (1) CA3240044A1 (https=)
IL (1) IL313526A (https=)
WO (1) WO2023114971A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006006432D1 (de) * 2005-03-24 2009-06-04 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
ES2731298T3 (es) * 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
EP2334279A4 (en) * 2008-10-16 2013-03-20 Novan Inc STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS
WO2015138406A1 (en) * 2014-03-14 2015-09-17 12th Man Technologies, Inc. Treating diseases using nitric oxide releasing solutions
WO2016160089A1 (en) * 2015-03-27 2016-10-06 Novan, Inc. Topical antiviral compositions, delivery systems, and methods of using the same
CA2919733A1 (en) * 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
CN109310630A (zh) * 2016-04-13 2019-02-05 诺万公司 用于治疗感染的组合物、系统、试剂盒和方法
BR112021023632A2 (pt) * 2019-06-04 2022-04-19 Thirty Respiratory Ltd Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório
CN112791096A (zh) * 2020-12-31 2021-05-14 南京诺令生物科技有限公司 一种可自提供一氧化氮的洗鼻盐及其应用

Similar Documents

Publication Publication Date Title
RU2524304C2 (ru) Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций
CN1352550A (zh) 酸性缓冲的鼻用喷雾剂
US12138343B2 (en) Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2
TR201807714T4 (tr) İnhalasyon tedavisine yönelik nebülize antibiyotikler.
CZ20033580A3 (cs) Aerosolový prostředek
WO2017212422A1 (en) Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
US20210353650A1 (en) Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation
RU2339403C2 (ru) Композиции для профилактики и лечения симптомов, подобных симптомам простуды и гриппа, содержащие выбранные склеивающиеся со слизистой полимеры, и способы лечения
JP2008535918A (ja) 感染性の症状を処置するための四級アンモニウムハライド
CN111686125A (zh) 卡拉胶在抗新型冠状病毒中的应用
WO2016067283A1 (en) Virucidal compositions comprising tannins for nasal and pulmonary administration
ES2928399T3 (es) Composición farmacéutica bactericida que comprende ibuprofeno
JPWO2023114971A5 (https=)
CN120154635A (zh) 应用消毒剂组合物进行病毒的传播预防
JP2024128022A (ja) 微生物感染を消毒、処置および予防するための組成物および方法
CN115551477A (zh) 用于治疗呼吸道病原体的碘化合物
NL2025641B1 (en) Methods and compositions for improved treatment of sinus disease
US20230158067A1 (en) Silver nanoparticles for use in inhibiting and treating coronavirus infection
WO2022046668A1 (en) Compositions and methods for reducing the transmissivity of illnesses
AU2021287456A1 (en) Improved virucidal formulations
JP5311825B2 (ja) 2−イミダゾリン構造を有するα−交感神経興奮薬の新規な使用
AU2021203846B2 (en) Virucidal formulations containing povidone-iodine
JP2024547022A (ja) 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法
WO2023083850A1 (en) Medicament for inhalation or breathing, and inhaler or breathing device comprising same
JPWO2021207178A5 (https=)